Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Malignant Solid Neoplasm · Advanced Biliary Tract Carcinoma · Advanced Esophageal Carcinoma · Metastatic Esophageal Carcinoma · Locally Advanced Colorectal Carcinoma · Locally Advanced Esophageal Carcinoma · Locally Advanced Gastric Carcinoma · Metastatic Colorectal Carcinoma (mCRC) · Advanced Lung Carcinoma · Locally Advanced Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • OHSU Knight Cancer Institute, Portland, Oregon, United States

    Contact: Study coordinator (Eric Roeland, M.D., FAAHPM, FASCO) · roeland@ohsu.edu · 503-494-8534
    Contact: Principal Investigator (Eric Roeland, M.D., FAAHPM, FASCO)
Study leads
  • Eric Roeland, M.D., FAAHPM, FASCO

    Principal Investigator

    OHSU Knight Cancer Institute